Hoechst Marion Roussel ending collaborations with Alteon and Scios.
Executive Summary
HOECHST ENDING COLLABORATIONS WITH ALTEON AND SCIOS as part of Hoechst Marion Roussel's continuing efforts to pare the network of external research collaborations created by the merger of Hoechst and Marion Merrell Dow. After ending its agreements with Alteon for diabetes and Scios for Alzheimer's, HMR will have eliminated a total of three agreements brought to the company by Marion. HMR announced plans to end its collaboration with ImmuLogic in March ("The Pink Sheet" March 18, p. 15).